C9ORF72 Antikörper (AA 110-199)
Kurzübersicht für C9ORF72 Antikörper (AA 110-199) (ABIN7539802)
Target
Alle C9ORF72 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 110-199
-
Verwendungszweck
- C9orf72 Antibody
-
Aufreinigung
- Purified antibody
-
Immunogen
- Purified recombinant fragment of human C9orf72 (AA: 110-199) expressed in E. Coli.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
-
ELISA: 1/10000
FCM: 1/200 - 1/400
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- Purified antibody in PBS with 0.05 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
-
-
- C9ORF72 (Chromosome 9 Open Reading Frame 72 (C9ORF72))
-
Andere Bezeichnung
- C9orf72
-
Hintergrund
-
The protein encoded by this gene plays an important role in the regulation of endosomal trafficking, and has been shown to interact with Rab proteins that are involved in autophagy and endocytic transport. Expansion of a GGGGCC repeat from 2-22 copies to 700-1600 copies in the intronic sequence between alternate 5' exons in transcripts from this gene is associated with 9p-linked ALS (amyotrophic lateral sclerosis) and FTD (frontotemporal dementia) (PMID: 21944778, 21944779). Studies suggest that hexanucleotide expansions could result in the selective stabilization of repeat-containing pre-mRNA, and the accumulation of insoluble dipeptide repeat protein aggregates that could be pathogenic in FTD-ALS patients (PMID: 23393093). Alternative splicing results in multiple transcript variants encoding different isoforms.
-
Molekulargewicht
- 54.3 kDa
-
UniProt
- Q96LT7
Target
-